Fresenius SE & Co KGaA operates within the Kidney dialysis centers sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fresenius SE & Co KGaA with three other
health care providers in Europe:
Fresenius Medical Care AG & Co. KGaA
sales of 16.55 billion Euro [US$18.26 billion]
of which 70%
was North America),
Ramsay Generale De Sante SA
(2.24 billion Euro [US$2.47 billion]
of which 79%
was Hospitals/Surgery), and
based in France
(3.42 billion Euro [US$3.77 billion]
During the year ended December of 2018, sales at
Fresenius SE & Co KGaA were 33.53 billion Euro (US$37.01 billion).
decrease of 1.1%
versus 2017, when the company's sales were 33.89 billion Euro.
Contributing to the drop in overall sales was the 60.0% decline
in Corporate/other, from 5.00 million Euro to 2.00 million Euro.
There were also decreases in sales in
Fresenius Medical Care (down 7.0% to 16.52 billion Euro)
However, these declines were partially offset by the increase in sales of
Fresenius Helios (up 3.8% to 8.98 billion Euro)
Fresenius Kabi (up 3.0% to 6.49 billion Euro)
Fresenius Vamed (up 31.3% to 1.54 billion Euro)